Our latest
Creative Biosciences
Good News | Lunsafe® Receives ANVISA Registration Approval in Brazil, Setting Sail for the Latin American Market!

On August 17, 2026, Lunsafe® — the Methylation Detection Kit for Human HOXB4 and SRCIN1 Genes (Real-Time PCR), independently developed by Creative Biosciences (Guangzhou) Co., Ltd. — was officially granted registration approval by Brazil’s National Heal

Aug 26 , 2026
Media Coverage
Authoritative media releases


Press releases
Creative Biosciences Shines at MEDICA 2024 in Germany, Accelerating Its Global Market Expansion
Nov 14 , 2024
Colosafe Was Showcased at the 46th Mexican National Clinical Chemists Conference in Mecixo City
Sep 15 , 2024
Colosafe® Showcased in the National "13th Five-Year" Scientific and Technical Innovation Achievement Exhibition
Nov 02 , 2021
Marvelous News! Creative Biosciences Won the National-Level Title of "Little Giant" Enterprise in the Category of Specialization, Refinement, Differentiation, and Innovation.
Sep 07 , 2024
Colosafe® Gains Market Entry in Brazil--Groundbreaking in South America!
Sep 04 , 2024
Broadening Global Expansion: CreativeBio Draws Attention at ADLM 2024
May 27 , 2024
CreativeBio Revealed Over 170,000 Prospective Clinical Application Data of Colosafe®
Jun 06 , 2022
Creative Biosciences & Cooper Biosciences MENA Announce Partnership for the Commercialization of Colosafe® in the MENA region
Nov 23 , 2022
CreativeBio Major Announcement: Over 830,000 Real-World Application Test Cases of Colosafe® Released
May 27 , 2024
Creative Biosciences (Hong Kong) Co., Ltd Has Been Established - Rooted in the Greater Bay Area, Oriented Towards The Global Market.
Mar 07 , 2023
The Annual Gala and All-Staff Meeting Has Successfully Concluded: United in Strength, Let the Dragon Soaring Across the Five Continents
Dec 26 , 2023
Creative Biosciences (Guangzhou) and DKSH Enters into a Strategic Partnership to Lead Reducing Cancer Burden in Asia
Apr 23 , 2021